These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2206824)

  • 21. Hyponatraemia during carbamazepine therapy in children.
    Koivikko MJ; Välikangas SL
    Neuropediatrics; 1983 May; 14(2):93-6. PubMed ID: 6877534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaceutical and biopharmaceutical quality of a sustained release carbamazepine preparation: a contribution to quality assurance.
    Grunwald F; Czaja J; Düsing R; Schulz HU
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):160-6. PubMed ID: 1592543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Side effects of phenobarbital and carbamazepine in childhood epilepsy: randomised controlled trial.
    Banu SH; Jahan M; Koli UK; Ferdousi S; Khan NZ; Neville B
    BMJ; 2007 Jun; 334(7605):1207. PubMed ID: 17145735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma levels of carbamazepine and carbamazepine-10,11-epoxide during treatment of epilepsy.
    Eichelbaum M; Bertilsson L; Lund L; Palmér L; Sjöqvist F
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):417-21. PubMed ID: 971704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbamazepine serum levels in children with epilepsy: a micro immuno-assay technique.
    Forsythe WI; Prendergast MP; Toothill C; Broughton PM
    Dev Med Child Neurol; 1979 Aug; 21(4):441-7. PubMed ID: 118072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum carbamazepine concentration and clinical control.
    Cereghino JJ
    Adv Neurol; 1975; 11():309-30. PubMed ID: 1217566
    [No Abstract]   [Full Text] [Related]  

  • 27. Bioavailability of two carbamazepine preparations during chronic administration to epileptic patients.
    Morselli PL; Monaco F; Gerna M; Recchia M; Riccio A
    Epilepsia; 1975 Dec; 16(5):759-64. PubMed ID: 1222752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlations between electroencephalographic tracings, epileptic seizures and blood levels of the drug in patients in long-term treatment with carbamezepine].
    Monaco F; Riccio A; Morselli PL; Mutani R
    Riv Neurol; 1978; 48(5):588-93. PubMed ID: 746313
    [No Abstract]   [Full Text] [Related]  

  • 29. Diurnal variation of carbamazepine and carbamazepine-10,11-epoxide in plasma and saliva in children with epilepsy: a comparison between conventional and slow-release formulations.
    Eeg-Olofsson O; Nilsson HL; Tonnby B; Arvidsson J; Grahn PA; Gylje H; Larsson C; Norén L
    J Child Neurol; 1990 Apr; 5(2):159-65. PubMed ID: 2111837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative open trial of carbamazepine and slow-release carbamazepine in epilepsy in adults].
    Remy C
    Presse Med; 1990 Mar; 19(11):511-3. PubMed ID: 2138749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbamazepine-10,11-epoxide in epilepsy. A pilot study.
    Tomson T; Almkvist O; Nilsson BY; Svensson JO; Bertilsson L
    Arch Neurol; 1990 Aug; 47(8):888-92. PubMed ID: 2375696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbamazepine as a single drug in the treatment of epilepsy. A prospective study of serum levels and seizure control.
    Callaghan N; O'Callaghan M; Duggan B; Feely M
    J Neurol Neurosurg Psychiatry; 1978 Oct; 41(10):907-12. PubMed ID: 731240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Slow release carbamazepine in treatment of poorly controlled seizures.
    Ryan SW; Forsythe I; Hartley R; Haworth M; Bowmer CJ
    Arch Dis Child; 1990 Sep; 65(9):930-5. PubMed ID: 2221963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Replacing carbamazepine slow-release tablets with carbamazepine suppositories: a pharmacokinetic and clinical study in children with epilepsy.
    Arvidsson J; Nilsson HL; Sandstedt P; Steinwall G; Tonnby B; Flesch G
    J Child Neurol; 1995 Mar; 10(2):114-7. PubMed ID: 7782600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative bioavailability and steady state fluctuations of Tegretol commercial and carbamazepine OROS tablets in adult and pediatric epileptic patients.
    Thakker KM; Mangat S; Garnett WR; Levy RH; Kochak GM
    Biopharm Drug Dispos; 1992 Nov; 13(8):559-69. PubMed ID: 1421050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A month-by-month long-term study on carbamazepine:clinical, EEG and pharmacological evaluation.
    Monaco F; Riccio A; Fantini M; Baruzzi A; Morselli PL
    J Int Med Res; 1979; 7(2):152-7. PubMed ID: 478161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How to initiate and maintain carbamazepine therapy in children and adults.
    Porter RJ
    Epilepsia; 1987; 28 Suppl 3():S59-63. PubMed ID: 3691421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment with carbamazepine: adults.
    Parsonage M
    Adv Neurol; 1975; 11():221-36. PubMed ID: 1217561
    [No Abstract]   [Full Text] [Related]  

  • 39. Carbamazepine and its 10,11-epoxide in children and adults with epilepsy.
    Pynnönen S; Sillanpää M; Frey H; Iisalo E
    Eur J Clin Pharmacol; 1977 Jan; 11(2):129-33. PubMed ID: 837966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbamazepine side effects in children and adults.
    Pellock JM
    Epilepsia; 1987; 28 Suppl 3():S64-70. PubMed ID: 2961558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.